Ledger.Open graph →
SEC Form D · filed September 2, 2015

NGX Bio, Inc

Offering
$600K
Sold
$300K
Exemption
Rule 506(b)
Industry
Biotechnology
Location
SAN FRANCISCO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (11)

Amit Kumar · San Francisco, CADirectorAlexi Andreev · San Francisco, CADirectorSam Tolkoff · San Francisco, CAExec · DirectorDmitri Petrov · San Francisco, CADirectorIra Rosenblum · New York, NYDirectorHans Hufschmid · New York, NYDirectorAndrea Dulberg · New York, NYExec · DirectorRonan A. Guilfoyle · Grand Cayman, Cayman IslandsDirectorElizabeth D. Obershaw · San Francisco, CAExec · DirectorMark M. Moore · San Francisco, CADirectorJon M. Roller · San Francisco, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗